AN2 Therapeutics (ANTX) Long-Term Investments (2021 - 2025)

AN2 Therapeutics (ANTX) has 5 years of Long-Term Investments data on file, last reported at $2.0 million in Q4 2025.

• On a quarterly basis, Long-Term Investments fell 59.91% year-over-year to $2.0 million in Q4 2025; TTM through Dec 2025 was $2.0 million, a 59.91% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, down 59.91% from the prior year.
• Long-Term Investments for Q4 2025 stood at $2.0 million, down from $3.2 million in the prior quarter.
• Over the last five years, Long-Term Investments for ANTX reached as high as $27.2 million in Q4 2023 and fell as low as $2.0 million in Q3 2022.
• Historically, Long-Term Investments has averaged $8.2 million across 5 years, with a median of $3.7 million in 2021.
• Across the five-year window, Long-Term Investments surged 1223.09% in 2023 and sank 81.54% in 2024, its largest moves.
• Year by year, Long-Term Investments stood at $3.5 million in 2021, then fell by 7.66% to $3.2 million in 2022, then soared by 744.8% to $27.2 million in 2023, then sank by 81.54% to $5.0 million in 2024, then sank by 59.91% to $2.0 million in 2025.
• Per Business Quant data, the three most recent Long-Term Investments figures were $2.0 million in Q4 2025, $3.2 million in Q3 2025, and $8.3 million in Q2 2025.